Select your Market

Sparking Discovery, Elevating Humanity

As a vibrant science and technology company, there's nothing small in what we do.

Impact to elevate humanity
21 May 2026
Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer
Phase 3 study is evaluating Precem-TcT for the treatment of metastatic colorectal cancer (mCRC).
What we do

Our passion for science and technology is what drives our more than 62,000 employees across 65 countries to find solutions to some of today’s toughest challenges and create more sustainable ways to live.

Life Science

Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services and expertise in order to perform experiments and engineer new products. That’s where we come in.

Healthcare

The work of our Healthcare business can help to make a difference to millions of lives. We put our patients at the center of everything we do.

Electronics

Discover why Electronics starts with us and how together with our customers, we are creating the next generation of materials, equipment and services that will advance our world.